REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 171 filers reported holding REVOLUTION MEDICINES INC in Q3 2023. The put-call ratio across all filers is 0.54 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $562,236 | +4.7% | 20,312 | +1.2% | 0.00% | 0.0% |
| Q2 2023 | $536,846 | +50.1% | 20,069 | +21.5% | 0.00% | +100.0% |
| Q1 2023 | $357,628 | -11.9% | 16,511 | -3.1% | 0.00% | 0.0% |
| Q4 2022 | $405,988 | +32.2% | 17,044 | +9.4% | 0.00% | 0.0% |
| Q3 2022 | $307,000 | +22.3% | 15,586 | +21.2% | 0.00% | 0.0% |
| Q2 2022 | $251,000 | -47.7% | 12,863 | -31.6% | 0.00% | 0.0% |
| Q1 2022 | $480,000 | -18.4% | 18,817 | -19.4% | 0.00% | 0.0% |
| Q4 2021 | $588,000 | -8.4% | 23,352 | +0.1% | 0.00% | -50.0% |
| Q3 2021 | $642,000 | -29.3% | 23,329 | -18.4% | 0.00% | -33.3% |
| Q2 2021 | $908,000 | -7.4% | 28,603 | +33.8% | 0.00% | 0.0% |
| Q1 2021 | $981,000 | +31.9% | 21,379 | +13.8% | 0.00% | 0.0% |
| Q4 2020 | $744,000 | – | 18,790 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,104,130 | $99,479,000 | 40.69% |
| Ponoi II Management, LLC | 685,011 | $13,351,000 | 36.28% |
| Nextech Invest Ltd. | 3,939,529 | $76,781,000 | 25.90% |
| Ponoi Management, LLC | 685,011 | $13,351,000 | 21.08% |
| Column Group LLC | 4,395,050 | $85,660,000 | 18.23% |
| TRV GP IV, LLC | 1,419,900 | $27,674,000 | 18.20% |
| Boxer Capital, LLC | 3,484,264 | $67,908,000 | 4.30% |
| Casdin Capital, LLC | 2,370,000 | $46,191,000 | 3.91% |
| Cormorant Asset Management, LP | 1,995,066 | $38,884,000 | 2.94% |
| EcoR1 Capital, LLC | 4,278,069 | $83,380,000 | 2.88% |